Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.58
+0.35 (5.62%)
At close: Dec 8, 2025, 4:00 PM EST
6.57
-0.01 (-0.15%)
Pre-market: Dec 9, 2025, 8:40 AM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $141.41 million as of December 9, 2025. Its market cap has increased by 180.91% in one year.
Market Cap
141.41M
Enterprise Value
98.98M
1-Year Change
180.91%
Ranking
Category
Stock Price
$6.58
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $141.41M, an increase of 112.69%. That is a compound annual growth rate of 18.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 133.89M | 62.42% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |